George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCOS.L Share News (COS)

  • There is currently no data for COS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK TRADING UPDATE SUMMARY: DP Eurasia Interim Sales Up On Turkey Rise

Tue, 21st Jul 2020 13:49

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News:

----------

DP Eurasia NV - master franchisee of the Domino's Pizza brand in Turkey, Russia, Azerbaijan and Georgia - Group system sales in six months to June 30 up 3.0% year on year to TRY664.7 million, about USD96.92 million, from TRY645.4 million. System sales up 14% in Turkey but down 15% in Russia. Sales up to March 15 - before Covid-19 lockdowns - sales up 20% year on year. From March 16 to June 30, sales down 8.7%. Online system sales in first half up 28% year on year. Total stores up to 754 from 736. "Through our experience during the first wave of the pandemic, we feel more comfortable that a full shut down of our stores in the future would be a very remote possibility. Assuming that we are not faced with significantly worse operational constraints, the group remains confident in its near-term plans for business continuity and cash flow as well as its overall prospects in the longer term," Chief Executive Aslan Saranga said.

----------

Alliance Pharma PLC - licenses the rights to 90 pharmaceutical and consumer products - Covid-19 hurt first half, with prescription medicines business sales down but consumer healthcare products have continued to be robust. Group see-through revenue for six months to June 30 down 7% year on year at GBP65.3 million. Based on trading in the year to date, the board expects revenue and underlying profit before tax for the full year to be in line with market expectations. Expects further recovery in trading in second half of year.

----------

Judges Scientific PLC - London-based scientific instrument sector investor - Organic sales in the first half were down 12% year on year. Organic order intake for the 6 months to 30 June was down 17% year on year. The organic order book, at 30 June, was "still satisfactory", Judges said, and represented 10.8 weeks of budgeted revenue against 13.2 weeks at the same point the year before. Judges noted, however, it operated profitably in each of the first six months of this year and generated positive operating cash-flow for the period. As a result, it was able to maintain a robust balance sheet with solid liquidity. Judges notes, despite encouraging signs, it "remains to be seen where and when demand, deliveries and installations will return to normal levels".

----------

Bloomsbury Publishing PLC - London-based fiction and non-fiction publisher - Seen "strong" trading in first four months of financial year - ended June 30 - with sales growth of 18% year on year. Total revenue in the four-month period was GBP49.5 million versus GBP42.1 million the year before. Print revenues were 9% above last year's sales and consumer division revenues were 28% ahead of last year, with strong print and e-book sales. "Our good May and June performance in particular were unexpected, and historically demand for books has been resilient in times of economic downturns. However, our customers are unclear about what is to follow. Our outlook in the next eight months therefore remains uncertain as the pandemic continues," Bloomsbury said.

----------

Midwich Group PLC - audio visual distributor - Revenue for six months to June 30 expected down 4% year on year, with a decline in underlying sales of around 22%. Midwich said it has taken actions to reduce operating expenditure meaning it expects be profitable in the first half, but at a level "significantly below" the same period last year. The company said the market conditions for its products and services are likely to remain significantly impacted by the development of the pandemic for the remainder of 2020, but believes it is well placed for future growth.

----------

Collagen Solutions PLC - developer and manufacturer of biomaterials - Performed "well", and recently finalised a number of contracts, including the Novabone supply agreement announced and a new supply agreement with an existing client for a long-term supply with larger contracted volumes. With the new contract in place, the company now has orders or contracted revenue for financial 2021, together with revenue already recognised through the first three months of the financial year, worth about GBP4.3 million, which is more than double the previous year.

----------

Kape Technologies PLC - London-headquartered digital security and privacy software business - Traded "strongly" in the first half, in line with internal expectations. Kape benefitted from higher demand for its privacy-based software solutions due to increased remote working and a full six months of contribution from PIA. First half - the six months to June 30 - revenue expected to be double to USD59.0 million from USD29.9 million. Adjusted Ebitda to be about USD16.1 million versus USD5.8 million the year before. Full year revenue expected between USD120 million to USD123 million.

----------

JKX Oil & Gas PLC - UK-based hydrocarbon exploration and production company - Ukrainian subsidiary Poltava Petroleum Co granted a new special permit for the Zaplavska field - for oil and gas production for a period of 20 years. This permit covers a total area of 173 square kilometres. The previous licence was valid until 2019.

----------

KRM22 PLC - software investment company - First half hurt by Covid-19 but progress has been made with two new customer wins and cost and debt reduction. June 30 annual recurring revenue of GBP4.0 million, but seen slowed business activity and extended sales cycles as customers and prospects have transitioned to home working and with the increased operational burden resulting from market volatility.

----------

Bidstack Group PLC - native in-game advertising firm - Revenue for six months to June 30 expected to be about GBP275,000 versus GBP27,000 the year before. Remains confident that it is making material progress in its approach to building a strong foundation on which to grow and create value for shareholders.

----------

Panoply Holdings PLC - IT service management company - Revenue for 12 months to March 31 expected at GBP31.5 million versus GBP22.1 million the year before. Adjusted Ebitda expected in line with market expectations. First-quarter performance was a "record", with revenue of GBP10.1 million and adjusted Ebitda of GBP1.7 million. "This performance has been achieved through the group's position as an alternative digital transformation provider to the UK public services sector at a time when the increased value provided by challengers has been acknowledged at senior ministerial level," Panoply said. As a result, the company expects full-year revenue and adjusted Ebitda significantly above current market expectations.

----------

Ergomed PLC - clinical development organisation - Had "excellent" first half, and now expects 2020 adjusted Ebitda materially ahead of current market expectations. First-half revenue up 15% year on year at GBP40.3 million. Overall growth in revenue driven by continued demand for its services across the integrated business, despite the global Covid-19 pandemic. "The continuing sales growth, healthy order book and financing capability position Ergomed firmly for further growth," the company added.

----------

GSTechnologies Ltd - data infrastructure, storage, and technology services firm - Expects hit from restrictions put in place due to Covid-19. However, the company has been able to access certain support from the government of Singapore including salary subsidies, together with the waiving of foreign worker levies, which will mitigate to a certain extent the impact of the pandemic. Singapore announced a stringent set of preventive lockdown measures initially from April 7 to May 4, but was subsequently extended to June 1. The country moved into Phase 2 of reopening on June 19 but subsidiary EMS Wiring Systems is still unable to be fully operational, and won't be until Phase 3 is triggered in the coming weeks, but has noted a gradual increase in activity.

----------

By Paul McGowan; paulmcgowan@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
20 Oct 2020 17:57

Collagen Solutions Says Offer From Rosen's Now Wholly Unconditional

Collagen Solutions Says Offer From Rosen's Now Wholly Unconditional

Read more
16 Oct 2020 16:04

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
6 Oct 2020 19:01

IN BRIEF: Collagen Solutions Suitor Has Acceptances Of 70%

IN BRIEF: Collagen Solutions Suitor Has Acceptances Of 70%

Read more
27 Aug 2020 15:12

Collagen Solutions Agrees Takeover Offer From Largest Shareholder

Collagen Solutions Agrees Takeover Offer From Largest Shareholder

Read more
31 Jul 2020 14:30

IN BRIEF: Collagen Solutions Annual Loss Widens But Highlights Rebound

IN BRIEF: Collagen Solutions Annual Loss Widens But Highlights Rebound

Read more
21 Jul 2020 09:15

Collagen Solutions upbeat on healthy order book

(Sharecast News) - Biomaterials and regenerative medicines developer Collagen Solutions updated the market on its order book and contracted development revenues on Tuesday, following the signing of a "significant" new contract.

Read more
10 Jul 2020 14:56

IN BRIEF: US Unit Of Collagen Solutions Gets USD150,000 Covid Loan

IN BRIEF: US Unit Of Collagen Solutions Gets USD150,000 Covid Loan

Read more
7 Jul 2020 14:37

Collagen Solutions Inks Supply Arrangement With NovaBone

Collagen Solutions Inks Supply Arrangement With NovaBone

Read more
7 Jul 2020 09:25

Collagen Solutions signs deal with Halma acquisition NovaBone

(Sharecast News) - Biomaterials and regenerative medicines developer Collagen Solutions has entered into a new minimum three-year agreement with NovaBone Products - a designer and manufacturer of US FDA-cleared synthetic bone grafts - it announced on Tuesday.

Read more
6 Jul 2020 21:33

IN BRIEF: Collagen Solutions Restructures Bond Repayment Plan

IN BRIEF: Collagen Solutions Restructures Bond Repayment Plan

Read more
15 Jun 2020 13:53

IN BRIEF: Collagen Solutions Order Book Strong; Trading In Line

IN BRIEF: Collagen Solutions Order Book Strong; Trading In Line

Read more
15 Jun 2020 08:07

Collagen Solutions sees no decrease in demand despite Covid-19

(Sharecast News) - Regenerative medicines maker Collagen Solutions said on Monday that while it has not seen any decrease in demand for its services or biomaterials products so far in this year, the group was wary of the potential external headwinds.

Read more
20 May 2020 12:37

Collagen Solutions gets Covid funding in US and New Zealand

(Sharecast News) - Collagen Solutions announced on Wednesday that its wholly-owned operating subsidiaries in the US and New Zealand have received a mix of loan and grant funding based on those governments' Covid-19 economic support programmes.

Read more
18 May 2020 10:46

UK WINNERS & LOSERS SUMMARY: Airlines Take Off After Ryanair Results

UK WINNERS & LOSERS SUMMARY: Airlines Take Off After Ryanair Results

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.